BCR‐ABL1 fusion oncogene that results from the Philadelphia (Ph+) chromosome t (9; 22) (q34; q11), is the hallmark of CML disease. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.